Estrogen News and Research

Latest Estrogen News and Research

Discovery of protein fragment that helps predict breast cancer outcome

Oregon Health & Science University Cancer Institute researchers have identified a protein fragment in some human breast cancers that may help predict a patient's chances of survival.

16 Jan 2006

New approaches to the treatment of osteoporosis

Medical researchers at the University of Bonn, working in collaboration with scientists from Israel, the USA and Britain, have identified a previously unknown regulatory mechanism in the process of bone loss. Their findings could open up new approaches to the treatment of osteoporosis.

6 Jan 2006

Research indicates birth control pill could cause long-term problems with testosterone

In the January issue of The Journal of Sexual Medicine, researchers have published a new investigation measuring sex hormone binding globulin (SHBG) before and after discontinuation of the oral contraceptive pill.

6 Jan 2006

Soy diet worsens heart disease in mice

Researchers from the University of Colorado have shown that mice carrying a genetic mutation that is linked to altered heart growth and function in humans, have significantly worse heart problems if fed a soy diet, when compared to mice fed a soy-free (milk protein-based) diet.

6 Jan 2006

New research indicates birth control pill could cause long-term problems with testosterone

4 Jan 2006

New hope for osteoporosis sufferers

4 Jan 2006

Identification of regulatory mechanism could lead to new treatments of osteoporosis

2 Jan 2006

New breast cancer drug Femara will save lives

Following the results of a worldwide study, U.S. regulators have given approval for the use of the drug Femara for women with early breast cancer directly after they have had surgery.

29 Dec 2005

A good year for breast cancer detection and treatment

It was a good year in women’s health, notably breast cancer treatment and detection. The December issue of Mayo Clinic Women’s HealthSource hails these important advances of 2005.

29 Dec 2005

Women suffering lupus OK to take oral contraceptives

Major study of women with either inactive or stable systemic lupus erythematosus (lupus) – a disease in which the body's immune system mistakenly attacks and damages healthy tissues of the skin, joints and internal organs – were able to take oral contraceptives without increased risk of flares, or periods of increased disease activity, that characterize the disease.

22 Dec 2005

Earlier hormone therapy trial scared women - but it was wrong!

According to new research the widely publicised 2002 study which apparently proved that hormone replacement therapy raised the risk of heart disease and breast cancer, was fundamentally flawed.

19 Dec 2005

Lupus patients safe to go back on the pill

Two new studies confirm that women who suffer from lupus, a chronic disease that can lead to inflamed kidneys, can safely take oral contraceptives without fear that the pill will worsen their condition.

19 Dec 2005

Common gene variation lessens Tamoxifen’s benefit

Researchers have discovered that one of the most commonly prescribed drugs for breast cancer, tamoxifen, may not be as effective for women who inherit a common genetic variation.

19 Dec 2005

Aromatase inhibitors may slow growth of lung cancer

A few years ago researchers discovered that, much like breast tumors, some lung tumors also thrive on estrogen. Now a medical student conducting research on a Howard Hughes Medical Institute (HHMI) fellowship and colleagues have managed to stop the growth of human lung cancer cells in mice with a class of breast cancer drugs called aromatase inhibitors.

15 Dec 2005

Perimenopause critical for preventing heart disease and osteoporosis

Research in monkeys suggests that the perimenopause - the five to 10 years before a woman's menopause - is a critical time for preventing heart disease and osteoporosis.

13 Dec 2005

NHS under pressure to provide new breast cancer drugs

The National Health Service in the UK is being put under considerable pressure by Cancer charities to widen access to a promising new class of breast cancer drug as new evidence suggests the latest treatment is far superior to Tamoxifen, the long established premier drug for women with the early stage of the disease.

12 Dec 2005

Risedronate prevents bone loss and periodontal disease

Drugs that reverse and prevent bone loss due to osteoporosis also significantly ward off periodontal disease, according to a graduate of the Case Western Reserve University School of Dental Medicine who reports in the current Menopause journal article, "Periodontal Assessments of Postmenopausal Women Receiving Risedronate."

7 Dec 2005